BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11363488)

  • 1. NIH scientists find cofactor for HIV entry. National Institutes of Health.
    James JS
    AIDS Treat News; 1996 May; (no 247):1, 6. PubMed ID: 11363488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elusive HIV co-factor identified.
    AIDS Alert; 1996 Jul; 11(7):83. PubMed ID: 11363554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIAID researchers identify cofactors for entry of HIV into cells. National Institute of Allergy and Infectious Diseases.
    Folkers G
    NIAID AIDS Agenda; 1996 Jun; ():1, 10-1. PubMed ID: 11363806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocytosis of HIV: anything goes.
    Permanyer M; Ballana E; Esté JA
    Trends Microbiol; 2010 Dec; 18(12):543-51. PubMed ID: 20965729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral entry discovery suggests new treatments.
    Smart T
    GMHC Treat Issues; 1996 May; 10(5):1-2. PubMed ID: 11363581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCI investigators find CD4 t-cell protectors.
    AIDS Alert; 2002 Aug; 17(8):100. PubMed ID: 12647688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV preferentially infects HIV-specific CD4+ T cells.
    Douek DC; Brenchley JM; Betts MR; Ambrozak DR; Hill BJ; Okamoto Y; Casazza JP; Kuruppu J; Kunstman K; Wolinsky S; Grossman Z; Dybul M; Oxenius A; Price DA; Connors M; Koup RA
    Nature; 2002 May; 417(6884):95-8. PubMed ID: 11986671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome instability: lessons from HIV.
    Medema JP; Medema RH
    Nat Cell Biol; 2002 Aug; 4(8):E191-3. PubMed ID: 12149628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Be strong against HIV. National Minority AIDS Council].
    Sidahora; 1997; ():36-8. PubMed ID: 11364806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM; Santos-Costa Q
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic science discovery: opening the door on HIV.
    PI Perspect; 1996 Sep; (No 19):17-8. PubMed ID: 11363902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To kill or be killed: how HIV exhausts the immune system.
    Gougeon ML
    Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
    [No Abstract]   [Full Text] [Related]  

  • 16. Limitations of therapy.
    AIDS Policy Law; 1997 May; 12(9):12. PubMed ID: 11364316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
    Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G
    Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication timetable setback.
    TreatmentUpdate; 1999 May; 11(3):3-4. PubMed ID: 11366780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.